Form 8-K ARRAY BIOPHARMA INC For: May 21
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Array BioPharma (ARRY) PT Raised to $35 at Piper Jaffray
May 21, 2019 12:24 PM EDTPiper Jaffray analyst Edward Tenthoff raised the price target on Array BioPharma (NASDAQ: ARRY) to $35.00 (from $28.00) while maintaining a Overweight rating.
BEACON Interim Analysis Hits, sNDA Filing in 2H:19... More


